Skip to main content
Log in

Change of body weight and lifestyle of persons at risk for diabetes after screening and counselling in pharmacies

  • Research Article
  • Published:
Pharmacy World & Science Aims and scope Submit manuscript

Abstract

Objective To investigate the effects of pharmacy based counselling on changes in lifestyle and body weight. Methods Three months after screening a stratified sample of 3,800 randomly chosen overweight persons were addressed with questionnaires. Half a year and 1 year later the assessment was repeated. Standard counselling (SC; non-specific recommendations towards lifestyle), intensive counselling (IC; additional advice to reduce body weight) and counselling for persons at high risk for type 2 diabetes (HRC; recommendation to contact a physician) were compared. Results All counselling groups (SC; n = 557, IC; n = 568, HRC; n = 245) showed significant weight loss three months after screening (0.6–1.9 kg). A further weight reduction was observed at 1 year follow up (1.1–2.4 kg). The HRC group showed a higher percentage of weight loss than the IC or SC group after 3 months (−2.25% vs. −1.20% and −0.67%; P < 0.001) and at 1 year of follow-up (−2.74% vs. −1.54% and −1.29%; P < 0.01). Lifestyle changes in physical activity and/or nutrition were reported by 81.2% in the HRC group, 74.1% in the IC group and 67.0% in the SC group. Conclusion Immediate counselling in community pharmacies after screening for type 2 diabetes can result in significant lifestyle changes and weight loss in overweight individuals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344(18):1343–50.

    Article  PubMed  CAS  Google Scholar 

  2. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346(6):393–403.

    Article  PubMed  CAS  Google Scholar 

  3. Hersberger KE, Botomino A, Mancini M, Bruppacher R. Sequential screening for diabetes—evaluation of a campaign in Swiss community pharmacies. Pharm World Sci 2006;28(3):171–9.

    Article  PubMed  Google Scholar 

  4. Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot 1997;12(1):38–48.

    PubMed  CAS  Google Scholar 

  5. James WP, Astrup A, Finer N, Hilsted J, Kopelman P, Rossner S, et al. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM study group. Sibutramine trial of obesity reduction and maintenance. Lancet 2000;356(9248):2119–25.

    Article  PubMed  CAS  Google Scholar 

  6. Sjostrom L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 1998;352(9123):167–72.

    Article  PubMed  CAS  Google Scholar 

  7. Dzien A, Dzien-Bischinger C, Lechleitner M. Seasonal fluctuation in body mass index. Clin Nutr. 2003;22(4):425–6.

    Article  PubMed  Google Scholar 

  8. Visscher TL, Seidell JC. Time trends (1993–1997) and seasonal variation in body mass index and waist circumference in the Netherlands. Int J Obes Relat Metab Disord 2004.

  9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106(25):3143–421.

    Google Scholar 

  10. Ahrens RA, Hower M, Best AM. Effects of weight reduction interventions by community pharmacists. J Am Pharm Assoc (Wash) 2003;43(5):583–9.

    Google Scholar 

Download references

Acknowledgements

We would like to thank all study participants, Prof. Dr. J. Drewe for support in statistical analysis and S. Mannstadt for her substantial assistance by processing the questionnaires.

Funding

This work was funded by the Swiss Federation of Pharmacists, Health Promotion Switzerland and 5 Swiss health insurances (action d).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kurt E. Hersberger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Botomino, A., Bruppacher, R., Krähenbühl, S. et al. Change of body weight and lifestyle of persons at risk for diabetes after screening and counselling in pharmacies. Pharm World Sci 30, 222–226 (2008). https://doi.org/10.1007/s11096-007-9174-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-007-9174-3

Keywords

Navigation